Literature DB >> 19570680

Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease.

Chi-Wei Huang1, Chun-Chung Lui, Weng-Neng Chang, Cheng-Hsien Lu, Ya-Ling Wang, Chiung-Chih Chang.   

Abstract

Elevated glucocorticoid concentrations, decreased hippocampal volume and frontal atrophy with poor cognitive function have been reported in the elderly but not extensively in Alzheimer's disease (AD). We enrolled 172 patients with AD over a 2-year follow-up period. Basal cortisol levels, biochemistry tests and mini-mental state examination (MMSE) scores were obtained and hippocampal and frontal atrophy were measured by CT scan for correlation. Basal plasma cortisol levels increased with age. Further, basal plasma cortisol levels were correlated with the radial width of the temporal horn, and elevated levels of plasma cortisol predicted a worse general cognitive performance. Higher plasma cortisol levels also correlated with rapid declines in MMSE scores after 2 years. Bilateral frontal atrophy showed no correlation with the above parameters. The relationship between high cortisol levels and hippocampal atrophy might adversely affect AD patients disproportionately, either in anatomical or cognitive function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570680     DOI: 10.1016/j.jocn.2008.12.026

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  47 in total

Review 1.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

2.  Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease.

Authors:  Yash B Joshi; Jin Chu; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer's disease.

Authors:  Yash B Joshi; Phillip F Giannopoulos; Jin Chu; Margaret Sperow; Lynn G Kirby; Mary E Abood; Domenico Praticò
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

4.  Volunteering, polygenic risk for Alzheimer's disease, and cognitive functioning among older adults.

Authors:  Sae Hwang Han; J Scott Roberts; Jan E Mutchler; Jeffrey A Burr
Journal:  Soc Sci Med       Date:  2020-04-02       Impact factor: 4.634

Review 5.  Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.

Authors:  Mythily Srinivasan; Debomoy K Lahiri
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

6.  Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice.

Authors:  A Di Meco; Y B Joshi; E Lauretti; D Praticò
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

7.  Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.

Authors:  David Baglietto-Vargas; Yuncai Chen; Dongjin Suh; Rahasson R Ager; Carlos J Rodriguez-Ortiz; Rodrigo Medeiros; Kristoffer Myczek; Kim N Green; Tallie Z Baram; Frank M LaFerla
Journal:  J Neurochem       Date:  2015-07-14       Impact factor: 5.372

Review 8.  One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition.

Authors:  Brett Friedler; Joshua Crapser; Louise McCullough
Journal:  Acta Neuropathol       Date:  2014-12-24       Impact factor: 17.088

Review 9.  The nonhuman primate hypothalamo-pituitary-adrenal axis is an orchestrator of programming-aging interactions: role of nutrition.

Authors:  Peter W Nathanielsz; Hillary F Huber; Cun Li; Geoffrey D Clarke; Anderson H Kuo; Elena Zambrano
Journal:  Nutr Rev       Date:  2020-12-01       Impact factor: 7.110

10.  Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative.

Authors:  Jon B Toledo; Estefanía Toledo; Michael W Weiner; Clifford R Jack; William Jagust; Virginia M Y Lee; Leslie M Shaw; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.